Immunomodulatory drugs are widely used in IBD therapy [178] and were shown to regulate galectin-3 protein levels in THP-1 cells differentiated into macrophages using phorbol-12-myristate-13-acetate. Here, LGALS3 is linked to inflammatory bowel disease.